Breaking news from “The Pink Sheet” DAILY
Executive Summary
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including the FDA Antiviral Drugs Advisory Committee's approval recommendation for Bristol's Baraclude (entecavir) for treatment of chronic hepatitis B infection and a Crestor "untitled" letter. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...